Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa

被引:92
|
作者
Harries, Anthony D. [1 ,2 ]
Zachariah, Rony [3 ]
Lawn, Stephen D. [2 ,4 ]
Rosen, Sydney [5 ,6 ]
机构
[1] Int Union TB & Lung Dis, Paris, France
[2] London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1, England
[3] Med Sans Frontieres, Dept Med, Brussels, Belgium
[4] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa
[5] Boston Univ, Ctr Int Hlth & Dev, Boston, MA 02215 USA
[6] Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa
关键词
HIV; AIDS; antiretroviral therapy; retention; treatment outcomes; lost to follow-up; Africa; FOLLOW-UP; COTRIMOXAZOLE PROPHYLAXIS; TREATMENT SERVICE; EARLY MORTALITY; SOUTH-AFRICA; CARE; HIV; PROGRAMS; INCOME; ADULTS;
D O I
10.1111/j.1365-3156.2010.02506.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
P>The scale-up of antiretroviral therapy (ART) has been one of the success stories of sub-Saharan Africa, where coverage has increased from about 2% in 2003 to more than 40% 5 years later. However, tempering this success is a growing concern about patient retention (the proportion of patients who are alive and remaining on ART in the health system). Based on the personal experience of the authors, 10 key interventions are presented and discussed that might help to improve patient retention. These are (1) the need for simple and standardized monitoring systems to track what is happening, (2) reliable ascertainment of true outcomes of patients lost to follow-up, (3) implementation of measures to reduce early mortality in patients both before and during ART, (4) ensuring uninterrupted drug supplies, (5) consideration of simple, non-toxic ART regimens, (6) decentralization of ART care to health centres and the community, (7) a reduction in indirect costs for patients particularly in relation to transport to and from clinics, (8) strengthening links within and between health services and the community, (9) the use of ART clinics to deliver other beneficial patient or family-orientated packages of care such as insecticide-treated bed nets, and (10) innovative (thinking 'out of the box') interventions. High levels of retention on ART are vital for individual patients, for credibility of programmes and for on-going resource and financial support.
引用
收藏
页码:70 / 75
页数:6
相关论文
共 50 条
  • [31] Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness
    Fox, Matthew P.
    Rosen, Sydney
    Geldsetzer, Pascal
    Baernighausen, Till
    Negussie, Eyerusalem
    Beanland, Rachel
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [32] Depression, Alcohol Use and Adherence to Antiretroviral Therapy in Sub-Saharan Africa: A Systematic Review
    Etheldreda Nakimuli-Mpungu
    Judith K. Bass
    Pierre Alexandre
    Edward J. Mills
    Seggane Musisi
    Malathi Ram
    Elly Katabira
    Jean B. Nachega
    [J]. AIDS and Behavior, 2012, 16 : 2101 - 2118
  • [33] Depression, Alcohol Use and Adherence to Antiretroviral Therapy in Sub-Saharan Africa: A Systematic Review
    Nakimuli-Mpungu, Etheldreda
    Bass, Judith K.
    Alexandre, Pierre
    Mills, Edward J.
    Musisi, Seggane
    Ram, Malathi
    Katabira, Elly
    Nachega, Jean B.
    [J]. AIDS AND BEHAVIOR, 2012, 16 (08) : 2101 - 2118
  • [34] Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa
    Sutcliffe, Catherine G.
    van Dijk, Janneke H.
    Bolton, Carolyn
    Persoud, Deborah
    Moss, William J.
    [J]. LANCET INFECTIOUS DISEASES, 2008, 8 (08): : 477 - 489
  • [35] Early antiretroviral therapy for HIV infection in sub-Saharan Africa, a challenging new step
    Laurent, Christian
    [J]. JOURNAL OF PUBLIC HEALTH POLICY, 2010, 31 (04) : 401 - 406
  • [36] Adherence to antiretroviral therapy in sub-Saharan Africa and North America - A meta-analysis
    Mills, Edward J.
    Nachega, Jean B.
    Buchan, Iain
    Orbinski, James
    Attaran, Amir
    Singh, Sonal
    Rachlis, Beth
    Wu, Ping
    Cooper, Curtis
    Thabane, Lehana
    Wilson, Kumanan
    Guyatt, Gordon H.
    Bangsberg, David R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (06): : 679 - 690
  • [37] Priorities for antiretroviral therapy research in sub-Saharan Africa - A 2002 consensus conference in Zambia
    Zulu, I
    Schuman, P
    Musonda, R
    Chomba, E
    Mwinga, K
    Sinkala, M
    Chisembele, M
    Mwaba, P
    Kasonde, D
    Vermund, SH
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (03) : 831 - 834
  • [38] Different delivery models for antiretroviral therapy to sub-Saharan Africa in the context of 'Universal Access'
    Harries, Anthony D.
    Makombe, Simon D.
    Schouten, Erik J.
    Ben-Smith, Anne
    Jahn, Andreas
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2008, 102 (04) : 310 - 311
  • [39] Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps
    Murphy, Richard A.
    Court, Richard
    Maartens, Gary
    Sunpath, Henry
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2017, 33 (12) : 1181 - 1184
  • [40] Neurocognitive improvement with antiretroviral therapy among HIV plus individuals in sub-saharan Africa
    Sacktor, Ned
    Nakasujja, Noeline
    Skolasky, Richard
    Liner, Jeff
    Robertson, Kevin
    Musisi, Seggani
    Katabira, Elly
    Ronald, Allan
    Clifford, David
    [J]. NEUROLOGY, 2007, 68 (12) : A139 - A140